Market closed

MiMedx Group/$MDXG

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About MiMedx Group

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Ticker

$MDXG
Trading on

Industry

Biotechnology

Employees

895

MiMedx Group Metrics

BasicAdvanced
$1.3B
Market cap
17.47
P/E ratio
$0.52
EPS
1.97
Beta
-
Dividend rate
$1.3B
1.97
$9.27
$5.47
880K
4.104
3.406
9.954
10.507
19.66%
18.38%
62.47%
17.471
3.703
7.36
8.85
22.772
10.93%
-2,191.21%
9.69%
17.46%

What the Analysts think about MiMedx Group

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for MiMedx Group stock.

MiMedx Group Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

MiMedx Group Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MDXG

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for MiMedx Group stock?

MiMedx Group (MDXG) has a market cap of $1.3B as of November 22, 2024.

What is the P/E ratio for MiMedx Group stock?

The price to earnings (P/E) ratio for MiMedx Group (MDXG) stock is 17.47 as of November 22, 2024.

Does MiMedx Group stock pay dividends?

No, MiMedx Group (MDXG) stock does not pay dividends to its shareholders as of November 22, 2024.

When is the next MiMedx Group dividend payment date?

MiMedx Group (MDXG) stock does not pay dividends to its shareholders.

What is the beta indicator for MiMedx Group?

MiMedx Group (MDXG) has a beta rating of 1.97. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.